Berry, C. , McClure, J. D. and Oldroyd, K. G. (2017) Meta-analysis of death and myocardial infarction in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a hypothesis generating note of caution. Circulation, 136(4), pp. 2389-2391. (doi: 10.1161/CIRCULATIONAHA.117.030430) (PMID:28972006) (PMCID:PMC5732639)

Layland, J. et al. (2017) Diagnostic accuracy of 3.0-T magnetic resonance T1 and T2 mapping and T2-weighted dark-blood imaging for the infarct-related coronary artery in Non-ST-segment elevation myocardial infarction. Journal of the American Heart Association, 6(4), e004759. (doi: 10.1161/JAHA.116.004759) (PMID:28364045) (PMCID:PMC5532996)

Nam, J. et al. (2015) Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Effectiveness and Resource Allocation, 2015(13), 19. (doi: 10.1186/s12962-015-0045-9) (PMID:26578850) (PMCID:PMC4647286)

Corcoran, D., Grant, P. and Berry, C. (2015) Risk stratification in non-ST elevation acute coronary syndromes: risk scores, biomarkers and clinical judgment. International Journal of Cardiology: Heart and Vasculature, 8, pp. 131-137. (doi: 10.1016/j.ijcha.2015.06.009) (PMID:26753174) (PMCID:PMC4691930)

Layland, J. et al. (2015) Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. European Heart Journal, 36(2), pp. 100-111. (doi: 10.1093/eurheartj/ehu338) (PMID:25179764) (PMCID:PMC4291317)

Layland, J. et al. (2015) Assessment of fractional flow reserve in patients with recent Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 8(8), e002207. (doi: 10.1161/circinterventions.114.002207) (PMID:26253733)

Layland, J., Carrick, D., Lee, M. , Oldroyd, K. and Berry, C. (2014) Adenosine: physiology, pharmacology, and clinical applications. JACC: Cardiovascular Interventions, 7(6), pp. 581-591. (doi: 10.1016/j.jcin.2014.02.009) (PMID:24835328)

Berry, C. et al. (2013) Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial. American Heart Journal, 166(4), 662-668.e3. (doi: 10.1016/j.ahj.2013.07.011)

Fearon, W. F., Low, A. F., Yong, A. S., McGeoch, R., Berry, C. , Shah, M. G., Ho, M. Y., Kim, H.-S., Loh, J. P. and Oldroyd, K. G. (2013) Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation, 127(24), pp. 2436-2441. (doi: 10.1161/CIRCULATIONAHA.112.000298)

Carrick, D., Behan, M., Foo, F., Christie, J., Hillis, W. S., Norrie, J., Oldroyd, K. G. and Berry, C. (2013) Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. American Journal of Cardiology, 111(1), pp. 45-50. (doi: 10.1016/j.amjcard.2012.08.046)

Layland, J. et al. (2013) Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Interventions, 6(3), pp. 231-236. (doi: 10.1161/CIRCINTERVENTIONS.112.000180)

Payne, A. R. et al. (2012) Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. Journal of the American Heart Association, 1(4), e002246. (doi: 10.1161/JAHA.112.002246)